NCT07315997Recruiting

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

Brigham and Women's Hospital

Start Date

9/4/2024

Completion Date

3/4/2028

Summary

Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start preventative treatment earlier.

Detailed Description

The objective of this study is to test the utility of high sensitivity cardiac troponin (hs-cTn) and coronary artery calcium (CAC) in risk stratifying patients with rheumatoid arthritis (RA) who may benefit from lipid lowering therapy. The population of interest are individuals who would not otherwise be recommended for therapy based on general population risk calculators for heart disease risk.

Eligibility Criteria

Age Range: 35 years to 79 years

Inclusion Criteria: * RA diagnosed by a rheumatologist * Age 40- 79 * ≥1 ASCVD risk factor including prediabetes, hypertension, BMI \>30, current or history of cigarette smoking Exclusion Criteria: * Patients on a statin or with a contraindication to statin, on a cholesterol absorption inhibitor, or on a PCSK9 inhibitor * Patients with diabetes mellitus * Pregnancy

Interventions

DIAGNOSTIC_TEST

high sensitivity cardiac troponin

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Rheumatoid Arthritis (RAAtherosclerotic Cardiovascular Disease (ASCVD)

Locations

Massachusetts General Hospital: Rheumatology

Boston, Massachusetts 02114

United States

Brigham and Womens Hospital

Boston, Massachusetts 02115

United States

Brigham and Women's Faulkner Hospital

Boston, Massachusetts 02130

United States